Drugs / senna glycoside
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT00390598 Comparator | Sep 2005 → Dec 2006 | — | Umeå University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | senna glycoside | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00390598 ↗ |
| Known as | Pursennid ExLax (R)= senna | “Pursennid ExLax (R)= senna” NCT00390598 ↗ |
| Route | Oral | “senna glycoside (Pursennid® Ex-Lax) 36mg (tablets) taken orally in the night before the colonoscopy” NCT00390598 ↗ |